Remote patient monitoring for chronic disease
Satelia has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in October 2022.
Satelia's investors include Impact Partners Nordic.
Satelia is headquartered in Bordeaux, France.
Remote patient monitoring for chronic disease
Satelia is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Satelia — Funding & Investors." VCBacked, October 25, 2022, https://www.vcbacked.co/company/satelia. Accessed September 30, 2026.
VCBacked. (2022). Satelia — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/satelia
{{cite web |title=Satelia — Funding & Investors |url=https://www.vcbacked.co/company/satelia |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated